Dr. Jan Vollert is a bioinformatician with a PhD in Neurophysiology from the Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Germany. His research focuses on the application of statistical and computational models in pain research, mainly in Quantitative Sensory Testing. He has conducted analyses of quantitative sensory testing data of patients suffering from neuropathic pain that have been largely acknowledged in the field.
He is a member of the International Association for the Study of Pain (IASP) and its Neuropathic Pain Special Interest Group, where he works on public outreach and trainee representation. He was invited speaker at congresses of the IASP, the NeupSIG, and the European Pain Federation. He published over 30 peer-reviewed papers, including several high impact papers in Pain, his h-index is 12 and his i10-index is 13.
Rice A, Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals, Bmj Open Science
et al., 2018, Sensory profiles and skin innervation of patients with painful and painless neuropathies, Pain, Vol:159, ISSN:0304-3959, Pages:1867-1876
et al., 2018, Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models, Pain, Vol:159, ISSN:0304-3959, Pages:1090-1102
et al., 2017, Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations, Pain, Vol:158, ISSN:0304-3959, Pages:1446-1455
et al., 2016, Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles, Pain, Vol:158, ISSN:0304-3959, Pages:261-272
et al., 2016, Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile, Brain, Vol:139, ISSN:0006-8950, Pages:1052-1065
et al., 2015, Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials, Pain, Vol:156, ISSN:0304-3959, Pages:1795-1802
et al., 2014, The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study, Pain, Vol:155, ISSN:0304-3959, Pages:2263-2273